Effects of combined hyperoxia and cyclooxygenase inhibition in neonatal rat lungs

American Journal of Translational Research

Volumn 2, Issue 3, 2010, Pages 332-344

  Kuniyoshi, Katherine M ^a   Brock, Romy S ^a   Gebrekristos, Bisrat H ^a   Abad Santos, Matthew ^b   Hoang, Dinh ^b   Modanlou, Houchang D ^a   Willis, Brigham C ^c   Beharry, Kay D ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b MILLER CHILDREN S HOSPITAL   (United States)

^c UNIVERSITY OF ARIZONA   (United States)

Author keywords

Antioxidants; DNA damage; Endothelins; Nitric oxide; Oxidative stress

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; ANTIOXIDANT; BIOLOGICAL MARKER; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENDOTHELIN 1; GLUTATHIONE PEROXIDASE; IBUPROFEN; INDOMETACIN; INDUCIBLE NITRIC OXIDE SYNTHASE; NITRIC OXIDE; OXYGEN; PROSTAGLANDIN F2 ALPHA; PROSTAGLANDIN SYNTHASE; SODIUM CHLORIDE;

AMBIENT AIR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BREATHING; COMPETITIVE INHIBITION; CONTROLLED STUDY; DNA DAMAGE; DOWN REGULATION; DRUG EFFECT; EARLY INTERVENTION; FEMALE; FETUS; HYPEROXIA; INJECTION; LUNG; LUNG ALVEOLUS; NEWBORN; NONHUMAN; OXIDATIVE STRESS; PERSISTENT PULMONARY HYPERTENSION; PREMATURITY; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION;

RATTUS;

EID: 77954663186     PISSN: None     EISSN: 19438141     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Srinivasjois RM, Nathan EA, Doherty DA, Patole SK. Renal impairment associated with indomethacin treatment for patent ductus arteriosus in extremely preterm neonates-is postnatal age at start of treatment important? J Matern Fetal Neonatal Med 2006;19:793-799.
2. Thomas RL, Parker GC, Van Overmeire B, Aranda JV. A meta-analysis of ibuprofen versus indomethacin for closure of patent ductus arteriosus. Eur J Pediatr 2005;164:135-140.
3. Zanardo V, Vedovato S, Lago P, Piva D, Faggian D, Chiozza L. Effects of ibuprofen and indomethacin on urinary antidiuretic hormone excretion in preterm infants treated for patent ductus arteriosus. Fetal Diagn Ther 2005;20:534-539.
4. Aranda JV, Thomas R. Systematic review: intravenous Ibuprofen in preterm newborns. Semin Perinatol 2006;30:114-120.
5. Van Overmeire B, Smets K, Lecoutere D, Van de Broek H, Weyler J, Degroote K, Langhendries JP. A comparison of ibuprofen and indomethacin for closure of patent ductus arteriosus. N Engl J Med 2000;343:674-681.
6. Bellini C, Campone F, Serra G. Pulmonary hypertension following L-lysine ibuprofen in preterm infant with patent ductus arteriosus. CMAJ 174:1843-1844, 2006.
7. Gournay V, Savagner C, Thiriez G, Kuster A, Rozé JC. Pulmonary hypertension after ibuprofen prophylaxis in very preterm infants. Lancet 2002;359:1486-1488.
8. Levin DL, Mills LJ, Weinberg AG. Hemodynamic, pulmonary vascular, and myocardial abnormalities secondary to pharmacologic constriction of the fetal ductus arteriosus. A possible mechanism for persistent pulmonary hypertension and transient tricuspid insufficiency in the newborn infants. Circulation 1979;60:360-364.
9. Mosca F, Bray M, Stucchi I, Fumagalli M. Pulmonary hypertension after ibuprofen prophylaxis in very preterm infants. Lancet 2002;360:1023-1024.
10. Tarcan A, Gurakan B, Yildirim S, Ozkiraz S, Bilezikci B. Persistent pulmonary hypertension in a premature newborn after 16 hours of antenatal indomethacin exposure. J Perinat Med 2004;32:98-9.
11. Fineman JR, Soifer SJ, Heymann MA. Regulation of pulmonary vascular tone in the perinatal period. Annu Rev Physiol 1995;57:115-134.
12. Levin DL, Fixler DE, Morriss FC, Tyson J. Morphologic analysis of the pulmonary vascular bed in infants exposed in utero to prostaglandind synthetase inhibitors. J Pediatr 1978;92:478-483.
13. de Vroomen M, Lopez-Cardoso RH, Steendijk P, Frolich M, Baan J, van Bel F. Endothelin-1 plasma concentration increases in the early phase of pulmonary hypertension development during respiratory distress syndrome: a study in newborn lambs. Early Hum Dev 2001;63:9-21.
14. de Lagausie P, de Buys-Roessingh A, Ferkdadji L, Saada J, Aisenfisz S, Martinez-Vinson C, Fund X, Cayuela JM, Peuchmaur M, Mercier JC, Berrebi D. Endothelin receptor expression in human lungs of newborns with congenital diaphragmatic hernia. J Pathol 2005;205:112-118.
15. Macdonald PD, Paton RD, Logan RW, Skeoch CH, Davis CF. Endothelin-1 levels in infants with pulmonary hypertension receiving extracorporeal membrane oxygenation. J Perinatal Med 1999;27:216-220.
16. Endo A, Ayusawa M, Minato M, Takada M, Takahashi S, Harada K. Endogenous nitric oxide and endothelin-1 in persistent pulmonary hypertension of the newborn. Eur J Pediatr 2001;160:217-222.
17. Kumar P, Kazzi NJ, Shankaran S. Plasma immunoreactive endothelin-1 concentrations in infants with persistent pulmonary hypertension of the newborn. Am J Perinatol 1996;13:335-341.
18. Rosenberg AA, Kennaugh J, Koppenhafer SL, Loomis M, Chatfield BA, Abman SH. Elevated immunoreactive Endothelin-1 levels in newborn infants with persistent pulmonary hypertension. J Pediatr 1994;124:489-490.
19. Awad JA, Roberts LJ, Burk RF, Morrow JD. Isoprostanesprostaglandin-like compounds formed in vivo independently of cyclooxygenase. NSAIDs Eicosanoids, and the Gastroenteric Tract 1996;25: 409-427.
20. Jankov RP, Luo X, Cabacungan J, Belcastro R, Frndova H, Lye SJ, Tanswell AK. Endothelin-1 and O2-mediated pulmonary hypertension in neonatal rats: a role for products of lipid peroxidation. Pediatr Res 2000;48:289-298.
21. Kinsella BT, O'Mahony DJ, Fitzgerald GA. The human thromboxane A2 receptor a isoform (TPa) functionally couples to the G proteins G9 and G11 in vivo and is activated by the isoprostane 8-epi prostaglandin F2a. J of Pharmacol Exper Ther 1997;281:957-964.
22. Kromer BM, Tippins JR. The vasoconstrictor effect of 8-epi prostaglandin F2a in the hypoxic rat heart. Br J Pharmacol 1999;126:1171-1174.
23. Montuschi P, Ciabattoni G, Paredi P, Pantelidis P, du Bois RM, Kharitonov SA, Barnes PJ. 8 Isoprostane as a biomarker of oxidative stress in interstitial lung diseases. Am J Respir Crit Care Med 1998;158:1524-1527.
24. Roberts LJ, Morrow JD. The generation and actions of isoprostanes. Biochem Biophys Acta 1997;1345:121-135.
25. Ahola T, Fellman V, Kjellmer I, Raivio KO, Lapatto R. Plasma 8-isoprostane is increased in preterm infants who develop bronchopulmonary dysplasia or periventricular leukomalacia Pediatr Res 2004;56:88-93.
26. Albrecht C, Knaapen AM, Becker A, Höhr D, Haberzettl P, van Schooten FJ, Borm PJ, Schins RP. The crucial role of particle surface reactivity in respirable quartz-induced reactive oxygen/ nitrogen species formation and APE/Ref-1 induction in rat lung. Respir Res 2005;6(1):129.
27. Farinati F, Cardin R, Degan P, Rugge M, Mario FD, Bonvicini P, Naccarato R. Oxidative DNA damage accumulation in gastric carcinogenesis. Gut 1998;42:351-356.
28. Halliwell B. Why and how should we measure oxidative DNA damage in nutritional studies? How far have we come? Am J Clin Nutr 2000;72:1082-1087.
29. Kim DH, Cho IH, Kim HS, Jung JE, Kim JE, Lee KH, Park T, Yang YM, Seong SY, Ye SK, Chung MH. Anti-inflammatory effects of 8-hydroxydeoxyguanosine in LPS-induced microglia activation: suppression of STAT3-mediated intercellular adhesion molecule-1 expression. Exp Mol Med 2006;38:417-427.
30. Witherell HL, Hiatt RA, Repogle M, Parsonnet J. Helicobacter pylori and urinary excretion of 8-hydroxy-2-deoxyguanosine, and oxidative DNA adduct. Cancer Epidem, Biomarkers & Prev 1998;7:91-96.
31. Kinnula VL, Crapo JD. Superoxide diusmutases in the lung and human lung diseases. Am J Respir Crit Care Med 2003;167: 1600-1619.
32. Cho HY, Jedlicka AE, Reddy SP, Kensler TW, Yamamoto M, Zhang LY, Keeberger SR. Role of NRF2 in protection against hyperoxic lung injury in mice. Am J Respir Cell Mol Biol 2002;26:175-182.
33. Ramos J, Matamoros MA, Naya L, James EK, Rouhier N, Sato S, Tabata S, Becana M. The glutathione peroxidase gene family of Lotus japonicus: characterization of genomic clones, expression analyses and immunolocalization in legumes. New Phytol 2009;181(1):103-114.
34. McCurnin DC, Pierce RA, Willis BC, Chang LY, Yoder BA, Yuhanna IS, Ballard PL, Clyman RI, Waleh N, Maniscalco W, Crapo JD, Grubb PH, Shaul PW. Postnatal estradiiol up-regulates lung nitric oxide synthases and improves lung function in bronchopulmonary dysplase. Am J Respir Crit Care Med 2009;179:492-500.
35. Vyas-Read S, Shaul PW, Yuhanna IS, Willis BC. Nitric oxide attenuates epithelial-mesenchymal transition in alveolar epithelial cells. Am J Physiol Lung Cell Mol Physiol 2007;293:L212-L221.
36. McCurnin DC, Pierce RA, Chang LY, Gibson LL, Osborne-Lawrence S, Yoder BA, Kerecman JD, Albertine KH, Winter VT, Coalson JJ, Crapo JD, Grubb PH, Shaul PW. Inhaled NO improves early pulmonary function and modifies lung growth and elastin deposition in a baboon model of neonatal chronic lung disease. Am J Physiol Lung Cel mol Physiol 2005;288:L450-L459.
37. Saugstad OD. Bronchopulmonary dysplasiaoxidative stress and antioxidants. Semin Neonatol 2003;8:39-49.
38. Gomez NN, Davicino RC, Biaggio VS, Bianco GA, Alvarez SM, Fischer P, Masnatta L, Rabinovich GA, Gimenez MS. Overexpression of inducible nitric oxide synthase and cyclooxygenase-2 in rat zinc-deficient lung: Involvement of a NF-kappaB dependent pathway. Nitric Oxide 2006;14:30-38.
39. Ovadia B, Bekker JM, Fitzgerald RK, Kon A, Thelitz S, Johengen MJ, Hendricks-Munoz K, Gerrets R, Black SM, Fineman JR. Nitric oxideendothelin1 interactions after acute ductal constriction in fetal lambs. Am J Physiol Heart Circ Physiol 2002;282:862-871.
40. Rosselli M, Keller PJ, Dubey RK. Role of nitric oxide in the biology, physiology and pathophysiology of reproduction. Human Reprod 1998;Update 4:3-24.
41. Salvemini D, Misko TP, Masferrer JL, Seibert K, Currie MG, Needleman P. et al. Nitric oxide activates cyclooxygenase enzymes. Proc Natl Acad Sci USA 1993;90:7240-7244.
42. Mallat A, Gallois C, Tao J, Habib A, Maclouf J, Mavier P, Préaux AM, Lotersztajn S. Plateletderived growth factor-BB and thrombin generate positive and negative signals for human hepatic stellate cell proliferation. Role of a prostaglandin/ cyclic AMP pathway and cross-talk with endothelin receptors. J Biol Chem 1998;273:27300-27305.
43. Yousufzai SY, Abdel-latif AA. Endothelin-1 stimulates the release of arachidonic acid and prostaglandins in cultrured human ciliary muscle cells: activation of phospholipase A2. Exp Eye Res 1997;65:73-81.
44. Burri PH. The postnatal growth of the rat lung III. Morphology. Anat Rec 1974;180:77-98.
45. Massaro D, Teich N, Maxwell S, Massaro GD, Whitney P. Postnatal development of alveoli. Regulation and evidence for a critical period in rats. J Clin Invest 1985;76:1297-1305.
46. Nagai A, Katayama M, Thurlbeck WM, Matsui R, Yasui S, Konno K. Effect of indomethacin on lung development in postnatal rats: possible role of prostaglandin in alveolar formation. Am J Phys 1995;268:L56-L62.